Can peptide receptor radionuclide therapy (PRRT) be useful in radioiodine-refractory differentiated thyroid cancer?
Crossref DOI link: https://doi.org/10.1007/s12020-014-0491-8
Published Online: 2014-12-04
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Campennì, Alfredo
Pignata, Salvatore A.
Baldari, Sergio
Text and Data Mining valid from 2014-12-04